MedKoo Cat#: 413633 | Name: Dextrallorphan

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dextrallorphan (DXA) is an chemical of the morphinan class that is used in scientific research. It acts as a σ1 receptor agonist and NMDA receptor antagonist. It has no significant affinity for the σ2, μ-opioid, or δ-opioid receptor, or for the serotonin or norepinephrine transporter. As an NMDA receptor antagonist, in vivo, it is approximately twice as potent as dextromethorphan, and five-fold less potent than dextrorphan. Dextrallorphan was found to have a half maximal inhibitory concentration (IC50) for binding to the pituitary and brain receptor of 10,000 ± 1000 nM and 10,000 ± 1500 nM, respectively. While its stereoisomer, levallorphan, had a 10,000 times more potent dose, thus proving that binding to these receptors is stereospecific.

Chemical Structure

Dextrallorphan
Dextrallorphan
CAS#5822-43-5 (free base)

Theoretical Analysis

MedKoo Cat#: 413633

Name: Dextrallorphan

CAS#: 5822-43-5 (free base)

Chemical Formula: C19H25NO

Exact Mass: 283.1936

Molecular Weight: 283.42

Elemental Analysis: C, 80.52; H, 8.89; N, 4.94; O, 5.65

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
177181-61-2 (HCl) 5822-43-5 (free base)
Synonym
Dextrallorphan
IUPAC/Chemical Name
Morphinan-3-ol, 17-(2-propenyl)-, (9alpha,13alpha,14alpha)-
InChi Key
OZYUPQUCAUTOBP-WDSOQIARSA-N
InChi Code
InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18-,19-/m0/s1
SMILES Code
[H][C@@]12CCCC[C@@]13C4=CC(O)=CC=C4C[C@]2([H])N(CC=C)CC3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 283.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Abbas H, Borde P, Willars GB, Ferry DR, Safrany ST. Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors. Front Pharmacol. 2020 Mar 13;11:309. doi: 10.3389/fphar.2020.00309. PMID: 32231573; PMCID: PMC7082753. 2: Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol. 1994 Jun 15;268(1):9-18. doi: 10.1016/0922-4106(94)90115-5. PMID: 7925616. 3: Ramabadran K, Sim MK, Lun KC. Neuromuscular effects of some opioid agonists and antagonists. Jpn J Pharmacol. 1983 Feb;33(1):73-8. doi: 10.1254/jjp.33.73. PMID: 6308317. 4: John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. Targeting sigma receptor- binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res. 1999 Sep 15;59(18):4578-83. PMID: 10493511. 5: Gebreselassie D, Bowen WD. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur J Pharmacol. 2004 Jun 16;493(1-3):19-28. doi: 10.1016/j.ejphar.2004.04.005. PMID: 15189760. 6: Su TP. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther. 1982 Nov;223(2):284-90. PMID: 6290634. 7: Hellewell SB, Bowen WD. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 1990 Sep 17;527(2):244-53. doi: 10.1016/0006-8993(90)91143-5. PMID: 2174717. 8: Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995 Jan 15;55(2):408-13. PMID: 7812973. 9: Torrence-Campbell C, Bowen WD. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions. Eur J Pharmacol. 1996 May 23;304(1-3):201-10. doi: 10.1016/0014-2999(96)00109-4. PMID: 8813603. 10: Baram D, Simantov R. Enkephalins and opiate antagonists control calmodulin distribution in neuroblastoma-glioma cells. J Neurochem. 1983 Jan;40(1):55-63. doi: 10.1111/j.1471-4159.1983.tb12652.x. PMID: 6294249.